Patents by Inventor Eric Bruckert

Eric Bruckert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of fibrates
    Patent number: 8501759
    Abstract: The present invention, which is applicable in the pharmaceutical industry, relates to the use of fibrates, in particular fenofibrate, especially in the form of a solid oral composition, for the manufacture of a drug for the treatment of sleep apnea, sleep apnea syndrome, in particular obstructive sleep apnea or obstructive sleep apnea syndrome.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: August 6, 2013
    Assignee: Fournier Laboratories Ireland Limited
    Inventor: Eric Bruckert
  • Novel Use of Fibrates
    Publication number: 20120035197
    Abstract: The present invention, which is applicable in the pharmaceutical industry, relates to the use of fibrates, in particular fenofibrate, especially in the form of a solid oral composition, for the manufacture of a drug for the treatment of sleep apnea, sleep apnea syndrome, in particular obstructive sleep apnea or obstructive sleep apnea syndrome.
    Type: Application
    Filed: December 31, 2009
    Publication date: February 9, 2012
    Applicant: Fournier Laboratories Ireland Limited
    Inventor: Eric Bruckert
  • Oatp-C Gene C463a Polymorphism Underlies Variable Response to Statin Therapy
    Publication number: 20080269188
    Abstract: The present invention relates to a method for determining variable response to statin therapy in patients afflicted with or susceptible to develop cardiovascular diseases, hypercholesterolemia, Diabetes and metabolic disorders involving high baseline plasma lipid level such as high LDL-C level, comprising detecting the presence or absence of the Pro 155T hr (C463A) variant in the Organic Anion Transporting Polypeptide-C(OATP-C) gene, wherein the presence of said variant is indicative of superior response to statin therapy. It also concerns tailored treatment of different populations of patients according to the Pro155Thr (C463A) variant genotype.
    Type: Application
    Filed: July 20, 2005
    Publication date: October 30, 2008
    Applicant: INSERM
    Inventors: John Martin Chapman, Philippe Giral, Alain Carrie, Sylvie Dejager, Eric Bruckert
  • Variants of apolipoprotein A-I
    Patent number: 6258596
    Abstract: The present invention relates to variants of the human apolipoproteine A-I comprising a cystein in position 151, the corresponding nucleic acids and the vectors containing them. It also relates to pharmaceutical compositions comprising said elements and their utilization, particularly in genic therapy.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: July 10, 2001
    Assignee: Aventis Pharmaceuticals Products Inc.
    Inventors: Patrick Benoit, Eric Bruckert, Patrice Denefle, Nicolas Duverger, Jean-Charles Fruchart, Gérald Luc, Gérard Turpin, Gerd Assmann, Harald Funke